期刊文献+

不同链长油相对葛根素微乳经淋巴转运吸收的影响 被引量:6

Effects of different chain length oils on lymphatic transport absorption of puerarin microemulsion
原文传递
导出
摘要 目的:以实验室前期研究得到的微乳处方为基础,采用乳糜微粒阻断法研究微乳处方中不同链长度油相对葛根素微乳经淋巴转运的影响。方法:采用乳糜微粒阻滞技术阻断药物淋巴转运,高效液相色谱法测定大鼠血浆中葛根素浓度,比较阻断组与未阻断组生物利用度来计算淋巴转运的比例。结果:长链油微乳的淋巴转运比例为49.7%,中链油微乳、及短链油微乳为29.8%、22.5%。长链油微乳的淋巴转运比例高于中链油微乳及短链油微乳,且其生物利用度也高于中链油微乳及短链油微乳,差异具有统计学意义。结论:长链油微乳更能促进葛根素经肠道吸收,增加其在血浆中的浓度,从而提高生物利用度。 OBJECTIVE To study the effects of different chain length oils on lymphatic transport absorption of puerarin microemulsion.METHODS The chylomicron flow blocking approach was used to block lymphatic transport of the microemulsion,and the concentration of puerarin in blood was determined by HPLC.Bioavailability of puerarin in cycloheximide treated rats and control rats were compared to calculate the proportion of puerarin absorbed through lymphatic transport.RESULTSThe lymphatic transport ratios for long,medium and short chain oil microemulsion were 49.7%,29.8% and 22.5% respectively.The proportion of puerarin absorbed by lymphatic transport was higher in long chain oil microemulsion than in medium or short chain oil microemulsion,and the difference was statistically significant.CONCLUSION Long chain oil microemulsion can enhance the absorption of puerarin,and thus improve its bioavailability.
出处 《中国医院药学杂志》 CAS 北大核心 2017年第15期1426-1430,共5页 Chinese Journal of Hospital Pharmacy
基金 湖南省自然科学基金项目(编号:08JJ3053)
关键词 葛根素 微乳 油相链长度 淋巴转运 puerarin microemulsion oil chain length lymphatic transport
  • 相关文献

参考文献2

二级参考文献16

  • 1秦浩,林志娟,陈景武.偏最小二乘回归原理、分析步骤及程序[J].数理医药学杂志,2007,20(4):450-451. 被引量:26
  • 2Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update [J]. Adv Drug Deliv Rev, 2001, 50 (1-2) : 61-80. 被引量:1
  • 3Charman WN, Porter CJH. Lipophilic prodrugs designed for intestinal lymphatic transport [J]. Adv Drug Deliv Rev, 1996, 19(2): 149-169. 被引量:1
  • 4Wasan KM. The role of lymphatic transport in enhancing oral protein and peptide drug delivery [J]. Drug Dev lnd Pharm, 2002, 28 (9) : 1047-1058. 被引量:1
  • 5Humberstone AJ, Porter C J, Edwards GA, et al. Association of halofantrine with postprandially derived plasma lipo- proteins decreases its clearance relative to administration in the fasted state [J]. JPharm Sci, 1998, 87 (8) : 936-942. 被引量:1
  • 6Charman WNA, Stella VJ. Estimating the maximal potentialfor intestinal lymphatic transport of lipophilic drug molecules [J]. lntJPharm, 1986, 34(1-2): 175-178. 被引量:1
  • 7Gershkovich P, Hoffman A. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability [ J]. Eur J Pharm Sci, 2005, 26 (5) : 394-404. 被引量:1
  • 8Porter C J, Trevaskis NL, Charman WN. Lipids and lipid- based formulations: optimizing the oral delivery of lipophilic drugs [J]. Nat Rev Drug Discov, 2007, {i (3) : 231-248. 被引量:1
  • 9Luchoomun J, Hussain MM. Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly [JJ. J Biol Chem, 1999, 274 (28) : 19565-19572. 被引量:1
  • 10Gershkovich P, Fanous J, Qadri B, et al. The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons [J]. J Pharm Pharmacol, 2009, 61 (1) : 31-39. 被引量:1

同被引文献60

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部